Abliva ABAbliva AB - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Alternative corporations in the rating industry group for Abliva AB are displayed. The analysis of Abliva AB is assembled by All Street Sevva using cutting edge NLP. Browse to the bottom of this page for potential risks for Abliva AB based on sector, location and marketcap.

Abliva AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.

SDG Transparency Score for Abliva AB 
Low
0 - 3
Medium
4 - 6

8.0

High Impact
7 - 10
Last Score Update: 2024-05-01
What drives the score for Abliva AB 
8.0

Environmental

8.0

Social

8.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Abliva AB
8.0
High
1Caladrius Biosciences Inc
8.0
High
1Can Fite Biopharma Ltd
8.0
High
.........
1970Zyden Gentec Ltd
0.0
Low
1970iNtRON Biotechnology Inc
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Abliva AB have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Abliva AB disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Abliva AB report the average age of the workforce?

LockedSign up for free to unlock

Does Abliva AB reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Abliva AB disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Abliva AB disclose cybersecurity risks?

LockedSign up for free to unlock

Does Abliva AB offer flexible work?

LockedSign up for free to unlock

Does Abliva AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Abliva AB disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Abliva AB conduct supply chain audits?

LockedSign up for free to unlock

Does Abliva AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Abliva AB conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Abliva AB disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Abliva AB disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Abliva AB disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Abliva AB disclose water use targets?

LockedSign up for free to unlock

Does Abliva AB have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Abliva AB have a product recall in the last two years?

LockedSign up for free to unlock

Does Abliva AB disclose incidents of discrimination?

LockedSign up for free to unlock

Does Abliva AB allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Abliva AB issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Abliva AB disclose parental leave metrics?

LockedSign up for free to unlock

Does Abliva AB disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Abliva AB disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Abliva AB disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Abliva AB support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Abliva AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Abliva AB reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Abliva AB involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Abliva AB disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Abliva AB disclose its waste policy?

LockedSign up for free to unlock

Does Abliva AB report according to TCFD requirements?

LockedSign up for free to unlock

Does Abliva AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Abliva AB disclose energy use targets?

LockedSign up for free to unlock

Does Abliva AB disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Abliva AB have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Abliva AB
These potential risks are based on the size, segment and geographies of the company.

Abliva AB (publ) develops medicines for the treatment of primary mitochondrial diseases. The company is developing KL1333 that is in Phase 2/3 clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT that is in Phase 1b/2a clinical study for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.

Sorry!

Failed to process!